marbox süstelahus
ceva sante animale - marbofloksatsiin - süstelahus - 100mg 1ml 100ml 1tk; 100mg 1ml 50ml 1tk
xofluza
roche registration gmbh - baloxavir marboxil - gripp, inimene - viirusevastased ravimid süsteemseks kasutamiseks - treatment of influenzaxofluza is indicated for the treatment of uncomplicated influenza in patients aged 1 year and above. post exposure prophylaxis of influenzaxofluza is indicated for post-exposure prophylaxis of influenza in individuals aged 1 year and above. xofluza should be used in accordance with official recommendations.
imvanex
bavarian nordic a/s - modifitseeritud vaktsiin ankara - baieri põhja (mva-bn) viirus - smallpox vaccine; monkeypox virus - muud viirusevaktsiinide - active immunisation against smallpox, monkeypox and disease caused by vaccinia virus in adults (see sections 4. 4 ja 5. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.
sycrest
n.v. organon - asenapine (as maleate) - bipolaarne häire - psühhoeptikumid - sycrest on näidustatud täiskasvanutele i tüüpi bipolaarse häirega seotud mõõdukate või raskete maniakaalsete episoodide raviks.
tecovirimat siga
siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - viirusevastased ravimid süsteemseks kasutamiseks - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 ja 5. tecovirimat siga should be used in accordance with official recommendations.
legacy® pro
adama - suspensioonikontsentraat - diflufenikaan + kloortoluroon + pendimetaliin - herbitsiidid
legacy® 500 sc
adama - suspensioonikontsentraat - diflufenikaan - herbitsiidid